Hyperbaric Oxygen and Fibromyalgia: Randomised Prospective Clinical Trial
CompletedNot applicableNCT01827683
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
The aim of the study is to evaluate the effect of hyperbaric oxygen therapy (HBOT) on patients suffering from chronic pain syndrome (Fibromyalgia).
Study details
- Official title
- The Effect of Hyperbaric Oxygen on Patients Suffering From Chronic Pain Syndrome (Fibromyalgia)
- Conditions
- Interventions
- Other: Hyperbaric oxygen
- Sponsor
- Assaf-Harofeh Medical Center
- Start date
- 2010-05
- Primary completion
- 2012-12
- Sex
- Female
- Age range
- from 45 Years to 65 Years
- Results posted
- No results posted in this snapshot
- Countries
- Israel
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * fibromyalgia diagnosed by physical examination of pain sensitivity, by Dolorimeter and finger pressure. Exclusion Criteria: * any past hyperbaric oxygen therapy * chest x-ray pathology which does not allow the income into the hyperbaric chamber. * middle ear problems. * patients, who cannot "pump", equals middle ear pressure, effectively. * patients who suffer from claustrophobia. * inability or Refusing to sign the Informed Consent Form
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT01827683